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Abstract
Objective: Evidence from family and molecular genetic studies support the hypothesis of involvement of immunologic mechanisms in the 
pathophysiology of obsessive-compulsive disorder. The nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 
1 (NFKBIL1) has been suggested as a modulator of the immunological system. Given the importance of NFKBIL1 in the immunological 
response, the present study investigated the -62A/T polymorphism (rs2071592), located in the promoter region of its gene (NFKBIL1), as 
a genetic risk factor for the development of obsessive-compulsive disorder. Method: The -62A/T NFKBIL1 polymorphism was investigated 
in a sample of 111 patients who met DSM-IV criteria for obsessive-compulsive disorder and 272 healthy age- and gender-matched 
controls. Results: There were no differences in genotypic distributions between patients and controls (χ2 = 0.98; 2 d.f.; p = 0.61). 
Discussion: Despite these negative findings, more comprehensive polymorphism coverage within the NFKBIL1 is warranted in larger 
samples. Populations with different ethnic backgrounds should also be studied. Conclusion: The results of the present investigation do 
not provide evidence for the association between the -62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder in this Brazilian 
sample.
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Resumo
Objetivo: Evidências advindas de estudos de família e de genética molecular têm dado suporte à hipótese do envolvimento de meca-
nismos imunológicos na fisiopatologia do transtorno obsessivo-compulsivo. Tem sido sugerido que o potencializador do fator nuclear 
do polipeptídeo kappa light em células-B inibidoras-like 1 (NFKBIL1) é um modulador do sistema imunológico. Dada a importância do 
NFKBIL1 na resposta imunológica, o presente estudo investigou o polimorfismo -62A/T (rs2071592), localizado na região promotora 
de seu gene, como fator de risco genético para o desenvolvimento do transtorno obsessivo-compulsivo. Método: O polimorfismo -62A/T 
do gene do NFKBIL1 foi investigado em uma amostra de 111 pacientes com o diagnóstico de transtorno obsessivo-compulsivo, de 
acordo com os critérios do DSM-IV, e 272 controles saudáveis emparelhados por idade e gênero. Resultados: Não houve diferenças 
na distribuição genotípica entre pacientes e controles (χ2 = 0,98; 2 d.f.; p = 0,61). Discussão: Apesar dos resultados negativos, 
estudos compreendendo mais polimorfismos no gene do NFKBIL, em amostras maiores, são necessários. Populações com diferentes 
origens étnicas também precisam ser avaliadas. Conclusão: Os resultados da presente investigação não evidenciam associação entre 
o polimorfismo -62A/T do gene do NFKBIL1 e o transtorno obsessivo-compulsivo nesta amostra brasileira.
Descritores: Estudos de casos e controles; Pacientes; Polimorfismo genético; Doenças do sistema imune; Transtorno obsessivo-compulsivo
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Introduction
Obsessive-compulsive disorder (OCD) is a psychiatric disorder 
characterized by obsessions (intrusive and recurrent thoughts, 
images or impulses) and compulsions (repetitive behaviors or 
mental acts usually performed to relieve the discomfort raised 
by the obsessions). OCD prevalence ranges from 2 to 3% in the 
general population, with equal gender distribution.1 The etiology of 
the disorder remains unknown, although twin and family studies 
and segregation analyses have provided consistent evidence that 
OCD presents a strong genetic component.2,3 Family studies have 
shown an increased prevalence of OCD among first-degree relatives 
of probands with OCD, suggesting that the risk for the development 
of the disorder is 3-12 times greater than that of first-degree relatives 
of control subjects.2 Twin studies have found higher concordance 
between monozygotic twin pairs when compared to dizygotic ones, 
suggesting, in children, a genetic influence in the range of 45% to 
65%, and in adults, ranging from 27% to 47%.3
OCD is a clinically heterogeneous disorder, with several possible 
subtypes.4 It has been hypothesized that certain forms of OCD may 
be associated with autoimmune disorders triggered by streptococcal 
infections [e.g., rheumatic fever (RF) and Sydenham’s chorea (SC)].4 
Children who develop acute OCD after a group A streptococcal 
infection have been described with the acronym PANDAS, for 
“pediatric autoimmune neuropsychiatric disorders after streptococcal 
infection”. These children develop OCD and tics, but do not manifest 
symptoms of RF or SC.5
Investigations have found higher prevalence of obsessive-
compulsive symptoms6,7 and OCD8 in patients with immunological 
diseases such as RF with or without SC. Family studies have 
reported that obsessive-compulsive spectrum disorders aggregate in 
first-degree relatives of RF probands.9 Recently, two polymorphisms 
of the promoter region of the tumor necrosis factor alpha gene 
(TNF-α) have been associated with RF. The same polymorphisms 
were associated with OCD in a previous study, using the same 
sample of this present investigation. This is an interesting finding, 
since TNF-α is a pro- inflammatory cytokine involved in RF and 
several other autoimmune diseases.10,11 Imbalance in cytokine 
production can result in the loss of appropriate immune responses 
and excessive inflammation, contributing to the severity of infection 
and progression of autoimmunity. The autoimmune hypothesis for 
neuropsychiatric disorders warrants studies focusing on cytokine 
genes.
Chromosome 6 has emerged as an interesting region for genetic 
studies of immunological system because it hosts the human major 
histocompatibility complex (MHC) class III region that harbors a 
wide variety of immune response genes. Susceptibility locus for 
many different immunological diseases has been found in this 
chromosomal region, such as multiple sclerosis, type 1 diabetes, 
chronic Chagas’ cardiomyopathy, rheumatoid arthritis, hepatitis 
C virus-associated dilated cardiomyopathy.12 The nuclear factor 
of kappa light polypeptide gene enhancer in B-cells inhibitor-
like 1 (NFKBIL1), homologous to the IKB family of proteins that 
regulate the NFKB family of transcription factors, is suggested as a 
putative inhibitor of NFKB, modulating the immunological system, 
and its gene is located in the MHC region, between the HLA-B-
associated transcript 1 (BAT1) and the TNF-β and TNF-α cluster 
on chromosome 6p21.3. Okamoto et al. have identified a diallelic 
polymorphism in the promoter region (adenine/thymine: -62A/T) 
of the NFKBIL1 gene (NFKBIL1), that represented the second 
rheumatoid arthritis susceptibility locus within the HLA region.13 
The -62A/T NFKBIL1 polymorphism seems to be functional. In a 
transient transfection of luciferase reporter assay, constructs that 
incorporate the -62A versus -62T sequences expressed lower levels 
of transcription of -62A allele compared with the -62T sequences.14 
However, if the lower or higher transcription rate has clinical 
implications is yet to be clarified.    
To evaluate the hypothesis of the involvement of other immune 
system related genes on OCD risk, it was performed an investigation 
with the -62A/T NFKBIL1 polymorphism (rs2071592) in 111 
DSM-IV OCD patients and 276 healthy controls as to evaluate 
its possible association with OCD. As far as we know, this is the 
first study investigating this polymorphism as a genetic risk factor 
for OCD.
Method
1. Sample
1) Patients: 111 participants who met the Diagnostic and 
Statistical Manual of Mental Disorders - 4th edition (DSM-IV) criteria 
for OCD were recruited from the Obsessive-Compulsive Spectrum 
Disorders Program at the Department of Psychiatry, Universidade 
de São Paulo Medical School. Patients underwent structured 
psychiatric evaluation with Structured Clinical Interview for DSM-IV 
(SCID-I)15 and additional modules for DSM-IV tic and impulse control 
disorders.7 More details about the evaluation of the present OCD 
sample can be found in Hounie et al.11 and Miguel et al.16
2) Controls: Unselected 272 age and sex matched healthy 
controls (unrelated bone marrow donors) were obtained from the 
Immunology Laboratory at the Heart Institute (InCor), Department 
of Clinical Medicine, Universidade de São Paulo Medical School.
All participants provided written informed consent. Ethical 
approval of the study was obtained from the Ethics Committee 
at the Hospital das Clínicas, Universidade de São Paulo Medical 
School (CAPPesq).
2. Genotyping
Fifteen milliliters of venous blood were collected from each subject 
and genomic DNA was extracted from lymphocytes. The investigated 
polymorphism was analyzed as follows: the polymorphism was 
identified by polymerase chain reaction followed by restriction 
fragment length polymorphism (PCR-RFLP). The following pair of 
primers flanking the polymorphisms was used for amplification: 
Forward 5′-CACAGTTCACTTCCGTCCTCCAGC-3′ and Reverse 
5 -CTGTGTTTAAGAAGCTCGG-3′. The underlined nucleotide 
denotes the introduction of a mismatch nucleotide for the creation 
of restriction site for PvuII. As to generate the polymerase chain 
reactions (PCR) products, the region of interest was amplified with 
primers. Ten microliters of PCR product were digested with 6 units 
of PvuII (New England Biolabs) in a final volume of 30 μL that 
contained 3 μL of 10× enzyme buffer. The resulting fragments were 
size-separated by electrophoresis in a 4% agarose gel. The fragment 
was cleaved into 23 bp and 84 bp while the -62A allele remains 
uncleaved by PvuII (107 bp).12 In order to avoid errors, genotyping 
was read by two independent trained research technicians. In case 
of disagreement, the process of genotyping was repeated.
3. Statistical analysis
We used standard statistical tests to compare the groups: t-test for 
continuous variables and chi-square for categorical data. We used 
the Excel program to test for polymorphism frequency differences 
and the Hardy-Weinberg equilibrium. Analyses were performed 
comparing the polymorphism frequencies between the groups of 
patients and controls, and subsequent analyses were also conducted 
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in order to compare these groups according to gender and presence 
of tics. The significance values adopted for all analyses were the 
standard 0.01, 0.05 and 0.1 significance levels to decide about 
highly, medium and low significant differences.   
Results
We found no significant differences between the groups regarding 
gender and age: 46% (n = 51/111) of females in the OCD group 
and 56,5% (n = 152/269) in the control group (χ2 = 1.39, 
p = 0.49) and 30.8 years (sd = 12.63; 95% CI 28.34-32.27) for 
the OCD group and 28.5 years (sd = 13.6; 95%CI 26.69-30.32) 
for controls (t = -1.44; sd = 13.3; p = 0.15), respectively. There 
were 3 missing values for gender and 57 missing values for age in 
the control group while on the OCD group there were 10 missing 
values for age. The genotypic distributions were in Hardy-Weinberg 
equilibrium in patients (p = 0.96) and controls (p = 0.65). We 
found no differences between OCD patients and controls regarding 
the genotypic distributions (χ2 = 0.98; 2 d.f.; p = 0.61) (Table 
1). When the analyses were performed according to gender 
and presence of tics, differences were not find as well (Gender: 
1- females: χ2 = 0.04; 2 d.f.; p = 0.97; 2-males: χ2 = 1.61; 
2 d.f.; p = 0.44; Presence of tics: χ2 = 1.34; 2 d.f.; p = 0.51). 
Considering that the homogeneity of the genotypic proportions 
between the groups of patients and controls was not rejected 
(H: p1 = q1, p2 = q2 and p3 = q3), and for this reason 
any function of these proportions could not be also rejected 
(H´: p1+0.5p2 = q2+0.5q2), there was no need to conduct 
the allelic analysis (a function of the genotypic proportions); 
nonetheless, the allelic frequencies may be found in Table 1.
studies that used ancestry-informative markers to conclude that in 
Brazil, at an individual level, phenotypic information, as determined 
by physical evaluation, was a poor predictor of genomic ancestry, 
better estimated by molecular markers. This particular genetic 
admixture condition makes it more difficult to achieve ethnic 
matching in case-controls studies. The fact that in the present study 
patients and controls were in Hardy-Weinberg equilibrium may be 
an indication that population stratification was not necessarily a 
problem. Nevertheless, we are aware that ethnic admixture may 
have been a limitation of the present work. 
A second limitation is the sample size. In the polygenic and 
multifactor model of the pathophysiology of OCD, it has been 
hypothesized that there may be several additive genes, each of 
them with a small contribution for the OCD phenotype.19 Thus, 
the chance of detecting these putative genes may be reduced in 
relatively small samples. Our effort to overcome this limitation has 
been to calculate the power sample as 90%. Another point to be 
considered is that, in Psychiatry, environmental factors may be as 
important as the genetic ones, both contributing to the interaction 
that will be determinant. This interaction also varies according to 
the period of the neural development of each individual.20 Hence, 
future prospective, systematic longitudinal studies evaluating 
environmental factors in individuals at risk are warranted especially 
to investigate the possible relation between infection (i.e., group A 
beta-hemolytic streptococcal infection), the immunological system 
and the development of OCD.21
Despite the negative results of the present investigation, future 
studies with NFKBIL polymorphisms are welcomed because of the 
interesting region where this gene is located. The NFKBIL is around 
30 kb to the TNF-α at the telomeric end of the central MHC region.12 
As a previous study showed association between polymorphisms 
in the promoter region of the TNF-α and OCD in the same sample 
of the present study11 and knowing that this chromosomal region 
presents tight linkage disequilibrium,12 other polymorphisms of the 
NFKBIL may be an interesting focus for future investigation.
In conclusion, the results of this investigation do not provide evidence 
for the association between the -62A/T NFKBIL1 polymorphism and 
OCD in this Brazilian sample. More comprehensive polymorphism 
coverage within the NFKBIL1 region should be conducted in 
larger samples, with the inclusion of comparisons in potential 
subgroups (early- vs. late-onset OCD, or tic-related OCD), as well 
as investigations in samples with different ethnic backgrounds. 
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Discussion
In face of the evidence for the involvement of the immunological 
system in the pathophysiology of OCD, investigations with 
polymorphisms associated with the immune response in OCD 
patients are warranted. In the present investigation, we tested the 
association of the -62A/T NFKBIL1 polymorphism and OCD. We 
have found no evidence of genotypic association between OCD and 
the investigated polymorphism.
The most important limitation of the present study is related to 
the ethnic admixture that could lead to population stratification bias. 
The allelic frequency can be significantly different between ethnical 
populations reducing the power to detect associations. In order to 
handle such a problem, we can try to identify the ethnical origin of 
the participants and create more homogenous samples. However, 
Parra et al.17 and later Pimenta et al.18 have recently published 
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